Real-world data analysis of immune checkpoint inhibitors in stage III-IV adenocarcinoma and squamous cell carcinoma

Abstract Background This study was designed to investigate the clinical application, efficacy, and safety of immune checkpoint inhibitors (ICIs) in the treatment of lung cancer in the real world. Methods A retrospective, observational analysis was conducted on patients treated with ICIs in four tert...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Meiling Sun, Huaijun Ji, Ning Xu, Peng Jiang, Tao Qu, Yu Li
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BMC 2022-07-01
سلاسل:	BMC Cancer
الموضوعات:	Immune checkpoint inhibitors (ICIs) PD-L1 inhibitor NSCLC Objective response rate Disease control rate Median progression-free survival
الوصول للمادة أونلاين:	https://doi.org/10.1186/s12885-022-09843-3
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!